Generally, molecular docking of HSA and DNA with metallodrugs is of great importance in MDR cancer research as it allows for the prediction and analysis of how metallodrugs interact with these biological targets at the molecular level, providing insights into binding affinity, interaction sites, and binding modes [24,25]. Here, ALB is linked to cancer.